J&J`s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk [Tehran Times (Iran)]

Press/Media: Press / Media

PeriodNov 1 2018

Media coverage

1

Media coverage

  • TitleJ&J`s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk [Tehran Times (Iran)]
    Media name/outletPharmacy Choice
    CountryUnited States
    Date11/1/18
    PersonsRalph A Defronzo